Search Results - "SMOLKIN, Mark"

Disparities in telemedicine utilization among surgical patients during COVID-19 by Lattimore, Courtney M, Kane, William J, Fleming, Mark A, Martin, Allison N, Mehaffey, J. Hunter, Smolkin, Mark E, Ratcliffe, Sarah J, Zaydfudim, Victor M, Showalter, Shayna L, Hedrick, Traci L

“…Background Telemedicine has been rapidly adopted in the wake of the COVID-19 pandemic. There is limited work surrounding demographic and socioeconomic…”
Get full text

Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma by ERDAG, Gulsun, SCHAEFER, Jochen T, SMOLKIN, Mark E, DEACON, Donna H, SHEA, Sofia M, DENGEL, Lynn T, PATTERSON, James W, SLINGLUFF, Craig L

“…Immune cells infiltrating the microenvironment of melanoma metastases may either limit or promote tumor progression, but the characteristics that distinguish…”
Get full text

Prognostic value of albumin in patients with head and neck cancer by Danan, Deepa, Shonka Jr, David C., Selman, Yamil, Chow, Zenia, Smolkin, Mark E., Jameson, Mark J.

“…Objectives/Hypothesis Albumin is an indicator of nutritional status and has been investigated as a predictor of cancer survival and perioperative outcomes…”
Get full text

Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson disease by Barrett, Matthew J, Blair, Jamie C, Sperling, Scott A, Smolkin, Mark E, Druzgal, T Jason

“…OBJECTIVEDetermining baseline predictors of future psychosis in Parkinson disease (PD) may identify those at risk for more rapidly progressive disease, i.e., a…”
Get full text

Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson disease by Barrett, Matthew J, Sperling, Scott A, Blair, Jamie C, Freeman, Cody S, Flanigan, Joseph L, Smolkin, Mark E, Manning, Carol A, Druzgal, T Jason

“…ObjectiveA major contributor to dementia in Parkinson disease (PD) is degeneration of the cholinergic basal forebrain. This study determined whether…”
Get full text

PD-L1, PD-L2 and PD-1 expression in metastatic melanoma: Correlation with tumor-infiltrating immune cells and clinical outcome by Obeid, Joseph M., Erdag, Gulsun, Smolkin, Mark E., Deacon, Donna H., Patterson, James W., Chen, Leiping, Bullock, Timothy N., Slingluff, Craig L.

“…Therapeutic blockade of PD-1/PD-L1 can have dramatic therapeutic benefit in some patients; however, the prognostic associations of PD-1 and its ligands, in the…”
Get full text

Nonadherence to Biologic Therapies in Inflammatory Bowel Disease by Wentworth, Brian J, Buerlein, Ross C D, Tuskey, Anne G, Overby, M Ashley, Smolkin, Mark E, Behm, Brian W

“…Abstract Background Nonadherence to medications is common with patients with inflammatory bowel disease (IBD). The aim of this study was to assess adherence to…”
Get full text

The impact of cirrhosis and MELD score on postoperative morbidity and mortality among patients selected for liver resection by Zaydfudim, Victor M., Turrentine, Florence E., Smolkin, Mark E., Bauer, Todd B., Adams, Reid B., McMurry, Timothy L.

“…Independent associations between chronic liver disease, MELD, and postoperative outcomes among patients selected for liver resection have not been completely…”
Get full text

Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation by DeGraff, David J, Clark, Peter E, Cates, Justin M, Yamashita, Hironobu, Robinson, Victoria L, Yu, Xiuping, Smolkin, Mark E, Chang, Sam S, Cookson, Michael S, Herrick, Mary K, Shariat, Shahrokh F, Steinberg, Gary D, Frierson, Henry F, Wu, Xue-Ru, Theodorescu, Dan, Matusik, Robert J

“…Approximately 50% of patients with muscle-invasive bladder cancer (MIBC) develop metastatic disease, which is almost invariably lethal. However, our…”
Get full text

Somatic mutations show no clear association with red blood cell or human leukocyte antigen alloimmunization in de novo or therapy‐related myelodysplastic syndrome by Adkins, Brian D., Mehta, Ajay, Selesky, Margaret, Vittitow, Stephany, Smolkin, Mark E., Ratcliffe, Sarah J., Luckey, Chance J.

“…Background Myelodysplastic syndrome (MDS) is a marrow failure disease. As patients often require chronic transfusion, many develop red blood cell (RBC)…”
Get full text

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients by Melssen, Marit M, Petroni, Gina R, Chianese-Bullock, Kimberly A, Wages, Nolan A, Grosh, William W, Varhegyi, Nikole, Smolkin, Mark E, Smith, Kelly T, Galeassi, Nadejda V, Deacon, Donna H, Gaughan, Elizabeth M, Slingluff, Jr, Craig L

“…Cancer vaccines require adjuvants to induce effective immune responses; however, there is no consensus on optimal adjuvants. We hypothesized that toll-like…”
Get full text

Randomized Multicenter Trial of the Effects of Melanoma-Associated Helper Peptides and Cyclophosphamide on the Immunogenicity of a Multipeptide Melanoma Vaccine by SLINGLUFF, Craig L, PETRONI, Gina R, CHIANESE-BULLOCK, Kimberly A, SMOLKIN, Mark E, ROSS, Merrick I, HAAS, Naomi B, MEHREN, Margaret Von, GROSH, William W

“…This multicenter randomized trial was designed to test whether melanoma-associated helper peptides augment CD8(+) T-cell responses to a melanoma vaccine and…”
Get full text

Specialty-Specific Readmission Risk Models Outperform General Models in Estimating Hepatopancreatobiliary Surgery Readmission Risk by Turrentine, Florence E., McMurry, Timothy L., Smolkin, Mark E., Jones, R. Scott, Zaydfudim, Victor M.

“…Background Readmissions are costly and inconvenient for patients, and occur frequently in hepatopancreatobiliary (HPB) surgery practice. Readmission prediction…”
Get full text

Infrared thermography of cutaneous melanoma metastases by Shada, Amber L., MD, Dengel, Lynn T., MD, Petroni, Gina R., PhD, Smolkin, Mark E., MS, Acton, Scott, PhD, Slingluff, Craig L., MD

“…Abstract Background Differentiating melanoma metastasis from benign cutaneous lesions currently requires biopsy or costly imaging, such as positron emission…”
Get full text

Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial by Slingluff, Jr, Craig L, Petroni, Gina R, Olson, Walter C, Smolkin, Mark E, Ross, Merrick I, Haas, Naomi B, Grosh, William W, Boisvert, Marc E, Kirkwood, John M, Chianese-Bullock, Kimberly A

“…Purpose: Granulocyte/macrophage colony-stimulating factor (GM-CSF) administered locally together with vaccines can augment T-cell responses in animal models…”
Get full text

Characteristics, correlates, and assessment of psychosis in Parkinson disease without dementia by Barrett, Matthew J., Smolkin, Mark E., Flanigan, Joseph L., Shah, Binit B., Harrison, Madaline B., Sperling, Scott A.

“…Considering that psychosis in Parkinson disease (PD) is associated with worse outcomes, including dementia, we aimed to study the characteristics, correlates,…”
Get full text

PD-L1 expression in tumor cells and the immunologic milieu of bladder carcinomas: a pathologic review of 165 cases by Davick, Jonathan J., Frierson, Henry F., Smolkin, Mark, Gru, Alejandro A.

“…Programmed death ligand 1 (PD-L1) is a transmembrane protein that plays a major role in immune suppression. Its interaction with the receptor PD-1 results in…”
Get full text

More than Just the Number of Brain Metastases: Evaluating the Impact of Brain Metastasis Location and Relative Volume on Overall Survival After Stereotactic Radiosurgery by Emery, Ashley, Trifiletti, Daniel M., Romano, Kara D., Patel, Nirav, Smolkin, Mark E., Sheehan, Jason P.

“…Most evidence describing outcomes of patients with brain metastases is based on number of brain metastases, rather than location or volume. We evaluated the…”
Get full text

Determining the Association Between Unplanned Reoperation and Readmission in Selected General Surgery Operations by Turrentine, Florence E., Smolkin, Mark E., McMurry, Timothy L., Scott Jones, R., Zaydfudim, Victor M., Davis, John P.

“…Unplanned reoperations and unplanned readmissions can increase morbidity and mortality. Few studies however, have explored the association of reoperation and…”
Get full text

Characterization and comparison of innate and adaptive immune responses at vaccine sites in melanoma vaccine clinical trials by Melssen, Marit M., Pollack, Karlyn E., Meneveau, Max O., Smolkin, Mark E., Pinczewski, Joel, Koeppel, Alexander F., Turner, Stephen D., Sol-Church, Katia, Hickman, Alexandra, Deacon, Donna H., Petroni, Gina R., Slingluff, Craig L.

“…The strength and durability of systemic anti-tumor immune responses induced by cancer vaccines depends on adjuvants to support an immunogenic vaccine site…”
Get full text